Ikris PharmaAug 20, 20202 min17q22 loss Associated with Survival in Enzalutamide-Resistant mCRPCMen who have advanced prostate cancer are prescribed Enzalutamide alone or with hormone therapy to block the effects of testosterone on...
Ikris PharmaAug 19, 20204 minAll about Benign Prostatic Hyperplasia (BPH)The most common benign tumor that is found in men is characterized by the term Benign Prostatic Hyperplasia. To describe in simple words,...